4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-002193
Chief Financial Officer sold 10,000 shares at an average $139.94 ($1,399,390)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McAnear Justin J. · Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-04 | Exercise or conversion : show line 1 in the form | +10,000 | $5.04 | $50,400 | 30,774 | D |
| 2021-01-04 | Sale : show line 2 in the form | −2,000 | $139.08 | $278,152 | 28,774 | D |
| 2021-01-04 | Sale : show line 3 in the form | −6,036 | $139.91 | $844,525 | 22,738 | D |
| 2021-01-04 | Sale : show line 4 in the form | −1,764 | $140.78 | $248,331 | 20,974 | D |
| 2021-01-04 | Sale : show line 5 in the form | −200 | $141.91 | $28,382 | 20,774 | D |
| Open-market sales · 10,000 sh · avg $139.94 · $1,399,390 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-01-04 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −10,000 | $5.04 | 2028-11-02 | 10,000 | 470,159 | D |
Loading xslF345X03/doc4.xml…